Reformulated booster shots ready by September, White House says
Jul 29, 2022
The Biden administration is working on contracts for the reformulated booster doses.
Antibody levels after COVID-19 vaccination inversely linked to body weight
May 23, 2022
An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.
mRNA Vaccine more effective booster to ChAdOx1 nCoV-19
Oct 22, 2021
“Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine...
FDA could approve Pfizer booster shots for all adults this week
Nov 17, 2021
More than 30 million Americans already have gotten booster shots.
FDA questions strength of Johnson & Johnson booster shot data
Oct 13, 2021
The agency says a key test used by the company to measure immune response from booster shot six months after the original shot was likely not sensitive enough.
Immune response may vary with choice of COVID-19 booster
Dec 16, 2021
All seven vaccines tested boosted immunity following two doses of ChAdOx1 nCoV-19; six of seven did so following two doses of BNT162b2.
Risk for myocarditis low after third dose of BNT162b2 vaccine
Mar 24, 2022
The incidence of myocarditis among young men estimated to be 6.43 and 11.25 per 100,000 vaccines in the week to two weeks after third dose..
U.S. begins targeted vaccine rollout against monkeypox
Jun 29, 2022
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine.
Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
COVID-19 certification mandates may increase vaccine uptake
Dec 22, 2021
Country-specific information, such as prior vaccination uptake and vaccine hesitancy, may influence the effect of COVID-19 certification mandates.